Literature DB >> 16781150

Gram-scale synthesis of pinusolide and evaluation of its antileukemic potential.

E E Shults1, J Velder, H-G Schmalz, S V Chernov, T V Rubalova, Y V Gatilov, G Henze, G A Tolstikov, A Prokop.   

Abstract

Pinusolide (1), a known platelet-activating factor (PAF) receptor binding antagonist, was synthesized from lambertianic acid (2), a labdane-type diterpene readily accessible in multigram quantities from the Siberian pine tree. It was shown that 1 not only decreases the proliferation activity of tumor cells at relatively low concentrations but specifically induces apoptosis at 100 microM via the mitochondrial pathway in the Burkitt lymphoma cell line BJAB. Also, using primary lymphoblasts and leukemic cells from children with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), a significant DNA fragmentation in pinusolide-treated cells could be detected in an ex vivo apoptosis assay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16781150     DOI: 10.1016/j.bmcl.2006.05.077

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Exploration of cascade cyclizations terminated by tandem aromatic substitution: total synthesis of (+)-schweinfurthin A.

Authors:  Joseph J Topczewski; John G Kodet; David F Wiemer
Journal:  J Org Chem       Date:  2011-01-12       Impact factor: 4.354

2.  An Approach toward 17-Arylsubstituted Marginatafuran-Type Isospongian Diterpenoids via a Palladium-Catalyzed Heck-Suzuki Cascade Reaction of 16-Bromolambertianic Acid.

Authors:  Yurii V Kharitonov; Elvira E Shults
Journal:  Molecules       Date:  2022-04-20       Impact factor: 4.927

3.  Oligonucleotide microarray analysis of apoptosis induced by 15-methoxypinusolidic acid in microglial BV2 cells.

Authors:  Y Choi; S Y Lim; H S Jeong; K A Koo; S H Sung; Y C Kim
Journal:  Br J Pharmacol       Date:  2009-05-19       Impact factor: 8.739

4.  Natural products: Designing Russian medications.

Authors:  V A Stonik; G A Tolstikov
Journal:  Her Russ Acad Sci       Date:  2008-11-09       Impact factor: 0.560

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.